Top Markets
Coin of the day
SD BioSensor, Inc SD BioSensor, Inc

SD BioSensor, Inc

137310
Rang in aandelen #13253
SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced... SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.
Aandeelprijs
$4.23
Marktkapitalisatie
$506.22M
Verandering (1 dag)
-2.86%
Verandering (1 jaar)
-41.34%
Land
KR
Handel SD BioSensor, Inc (137310)

Categorie

P/S-ratio voor SD BioSensor, Inc (137310)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van SD BioSensor, Inc is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor SD BioSensor, Inc van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
12.63 -
US
2.55 -
FR
- -
JP
2.43 -
US
- -
CH